학술논문
PD‐L1 on large extracellular vesicles is a predictive biomarker for therapy response in tissue PD‐L1‐low and ‐negative patients with non‐small cell lung cancer
Document Type
article
Author
Source
Journal of Extracellular Vesicles, Vol 13, Iss 3, Pp n/a-n/a (2024)
Subject
Language
English
ISSN
2001-3078
Abstract
Abstract Immunotherapy has revolutionized the treatment of patients with non‐small cell lung cancer (NSCLC). High expression of tissue PD‐L1 (tPD‐L1) is currently the only approved biomarker for predicting treatment response. However, even tPD‐L1 low (1‐49%) and absent (